Search Write for us Sign in
OpenAI Daily News

Independent news about OpenAI and ChatGPT. Not an OpenAI publication.

Wednesday, October 21, 2026Sources checked

Business

OpenAI acquires AI drug development platform

Becker's Hospital Review

OpenAI acquired Orchestra Bio, a drug development platform, to pair with its Rosalind life sciences AI. Its agents flag how a failed batch can delay a trial.

Also carried by Interesting Engineering.

This report was first published by Becker's Hospital Review. What you see here is a brief excerpt. The full text is theirs.

Continue reading at Becker's Hospital Review

Pass it on X Facebook WhatsApp

More reports on this

Latest in Business

  1. OpenAI models are coming to Google Cloud

Everything in Business

Policy & Courts

ChatGPT